Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models release_l2fjgjfoonhd7bag26d6tr6zha

by Jing Ai, Yi Chen, Xia Peng, Yinchun Ji, Yong Xi, Yanyan Shen, Xinying Yang, Yi Su, Yiming Sun, Yinglei Gao, Yuchi Ma, Bing Xiong (+3 others)

Published in Molecular Cancer Therapeutics by American Association for Cancer Research (AACR).

2017   Volume 17, p751-762

Archived Files and Locations

application/pdf  14.4 MB
file_cfpah73marc7lnrkimuedcsiuq
mct.aacrjournals.org (web)
web.archive.org (webarchive)
application/pdf  1.8 MB
file_n2oycro3e5dgbkj4azhozl4fja
web.archive.org (webarchive)
mct.aacrjournals.org (web)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2017-12-13
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  1535-7163
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 9ea8c9ae-68dc-4b79-b4cb-884515dfee4d
API URL: JSON